Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia
Saved in:
| Published in: | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871022049009336320 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| description | |
| discipline_display | Gerontology and Geriatrics |
| discipline_facet | Gerontology and Geriatrics |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:104091 |
| institution | FRELIP |
| journal_source_facet | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| last_indexed | 2026-07-18T03:34:33.368Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia Gerontology and Geriatrics General Gerontology and Geriatrics |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Gerontology and Geriatrics General Gerontology and Geriatrics |
| subject_facet | Gerontology and Geriatrics General Gerontology and Geriatrics |
| title | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_alt | Resultados de PET amiloide del mundo real a los seis meses después de lecanemab: mayor reducción de amiloide en la etapa de DCL que en la demencia Résultats réels de la TEP amyloïde après six mois de lécanémab : une réduction amyloïde plus importante au stade MCI qu'à la démence Resultados reais da PET amiloide após seis meses de lecanemab: Maior redução amiloide no estágio de CCL do que na demência |
| title_auth | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_es_txt | Resultados de PET amiloide del mundo real a los seis meses después de lecanemab: mayor reducción de amiloide en la etapa de DCL que en la demencia |
| title_fr_txt | Résultats réels de la TEP amyloïde après six mois de lécanémab : une réduction amyloïde plus importante au stade MCI qu'à la démence |
| title_full | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_fullStr | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_full_unstemmed | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_pt_txt | Resultados reais da PET amiloide após seis meses de lecanemab: Maior redução amiloide no estágio de CCL do que na demência |
| title_short | Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia |
| title_sort | six‐month real‐world amyloid pet outcomes after lecanemab: greater amyloid reduction at the mci stage than in dementia |
| topic | Gerontology and Geriatrics General Gerontology and Geriatrics |
| url | https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70300?af=R |